Aditxt, Inc.

ADTX ·Healthcare, Drug Manufacturers - General, United States
Valuation › AI Valuation

AI Valuation

AI-generated fair value estimate for this company.

AI Fair Value $0.00
Market Price $0.00
vs. Fair Value —

Method: Going-concern basis: TTM revenue of just $14.3K (2025 revenue of $3,195, down 97.6% y/y) against a $3,670 total market capitalization, a $53.3M annual net loss, and ~815.9K shares outstanding after repeated reverse splits; per-share intrinsic value is $0.00.

Reasoning: Aditxt has essentially no revenue-generating operations left relative to its cost structure and trades for a few thousand dollars of total market value, so neither a DCF nor a multiple-based method is meaningful; the defensible real-calculation conclusion is that there is no discernible going-concern equity value for common shareholders today.